Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lindsey E. Dayer, Ross Wagner, Danviona King, Mrinmayee Lakkad, Leigh Ann Wilson, Collin Montgomery & Jacob T Painter. (2022) Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. Journal of Pain & Palliative Care Pharmacotherapy 36:4, pages 223-227.
Read now
Read now
Saumen Saha & Joydeep Chowdhury. (2021) Understanding the structure and conformation of bovine hemoglobin in presence of the drug hydroxyurea: multi-spectroscopic studies supported by docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 39:10, pages 3533-3547.
Read now
Read now
P Waller & AD Blann. (2019) Non-coding RNAs – A primer for the laboratory scientist. British Journal of Biomedical Science 76:4, pages 157-165.
Read now
Read now
Alexandra Kolliopoulou, Stavroula Siamoglou, Anne John, Argyro Sgourou, Alexandra Kourakli, Argiris Symeonidis, Efthymia Vlachaki, Panagiota Chalkia, Stamatia Theodoridou, Bassam R. Ali, Theodora Katsila, George P. Patrinos & Adamantia Papachatzopoulou. (2019) Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study. Hemoglobin 43:1, pages 27-33.
Read now
Read now
Articles from other publishers (55)
Nathan Lorde, Farheen Karim, Rousseau Gama & Tejas Kalaria. (2023) Acquired haemoglobin F (HbF) in HbA1c analysis predating a diagnosis of myelodysplastic syndrome. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.
Crossref
Crossref
Roberto Gambari, Cristina Zuccato, Lucia Carmela Cosenza, Matteo Zurlo, Jessica Gasparello, Alessia Finotti, Maria Rita Gamberini & Marco Prosdocimi. (2023) The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies. Biology 12:9, pages 1202.
Crossref
Crossref
Noemi BA Roy, Abigail Carpenter, Isabella Dale-Harris, Carolyn Dorée & Lise J Estcourt. (2023) Interventions for chronic kidney disease in people with sickle cell disease. Cochrane Database of Systematic Reviews 2023:8.
Crossref
Crossref
Mahfoud EID, Abd Ghanem & Elias Saloum. (2023) Cytomegalovirus viremia in an 11-year-old child with sickle cell disease manifested only with fever: a case report. Annals of Medicine & Surgery 85:7, pages 3666-3669.
Crossref
Crossref
Bhaskar V. K. S. Lakkakula & Smaranika Pattnaik. (2021) The HBG2 rs7482144 (C > T) Polymorphism is Linked to HbF Levels but not to the Severity of Sickle Cell Anemia. Journal of Pediatric Genetics 12:02, pages 129-134.
Crossref
Crossref
Ofelia A Alvarez, Hector Rodriguez-Cortes, E Leila Jerome Clay, Sandra Echenique, Julie Kanter, John J Strouse, Talia Buitrago-Mogollon, Cheryl Courtlandt, Laura Noonan & Ifeyinwa Osunkwo. (2023) Successful quality improvement project to increase hydroxyurea prescriptions for children with sickle cell anaemia. BMJ Quality & Safety, pages bmjqs-2022-015209.
Crossref
Crossref
Neha Kargutkar, Madhavi Sawant-Mulay, Priya Hariharan, S. Chandrakala & Anita Nadkarni. (2023) Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients. Scientific Reports 13:1.
Crossref
Crossref
Mohamed-Rachid Boulassel, Amal Al-Naamani, Abeer Al-Zubaidi, Zahra Al-Qarni, Hammad Khan, Amar Oukil, Amira Al-Badi, Juma Al-Kaabi, Jalila Al-Shekaili, Sulaiman Al-Hashmi, Fahad Zadjali, Rizwan Nabi Qureshi, Vinodh Panjwani & Salam Al-Kindi. (2022) Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells. Human Immunology 83:12, pages 818-825.
Crossref
Crossref
Alexander Dick, Gabrielle Schwartzman & Amor Khachemoune. (2022) Cutaneous manifestations of sickle cell disease: an updated review. Archives of Dermatological Research 315:4, pages 729-734.
Crossref
Crossref
Aline Renata Pavan, Juliana Romano Lopes, Carlos Henrique Lima Imperador, Chung Man Chin & Jean Leandro dos Santos. (2022) Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease. Frontiers in Medicine 9.
Crossref
Crossref
Sari Peretz, Leonid Livshits, Etheresia Pretorius, Asya Makhro, Anna Bogdanova, Max Gassmann, Ariel Koren & Carina Levin. (2022) The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism. Frontiers in Physiology 13.
Crossref
Crossref
Siti Nur Nabeela A’ifah Mohammad, Salfarina Iberahim, Wan Suriana Wan Ab Rahman, Mohd Nazri Hassan, Hisham Atan Edinur, Maryam Azlan & Zefarina Zulkafli. (2022) Single Nucleotide Polymorphisms in XMN1-HBG2, HBS1L-MYB, and BCL11A and Their Relation to High Fetal Hemoglobin Levels That Alleviate Anemia. Diagnostics 12:6, pages 1374.
Crossref
Crossref
Olayemi Adeniyi, Rafael Baptista, Sumana Bhowmick, Alan Cookson, Robert J. Nash, Ana Winters, Jianying Shen & Luis A. J. Mur. (2022) Isolation and Characterisation of Quercitrin as a Potent Anti-Sickle Cell Anaemia Agent from Alchornea cordifolia. Journal of Clinical Medicine 11:8, pages 2177.
Crossref
Crossref
Rahyssa Rodrigues Sales, Bárbara Lisboa Nogueira, Jéssica Abdo Gonçalves Tosatti, Karina Braga Gomes & Marcelo Rizzatti Luizon. (2022) Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Nirmani Yasara, Anuja Premawardhena & Sachith Mettananda. (2021) A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
John Brewin, Sara El Hoss, John Strouboulis & David Rees. (2021) A novel index to evaluate ineffective erythropoiesis in hematological diseases offers insights into sickle cell disease. Haematologica 107:1, pages 338-341.
Crossref
Crossref
Sunčica Kapor, Milica Vukotić, Tijana Subotički, Dragoslava Đikić, Olivera Mitrović Ajtić, Milica Radojković, Vladan P. Čokić & Juan F. Santibanez. (2021) Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro. Journal of Personalized Medicine 11:11, pages 1048.
Crossref
Crossref
Sunčica Kapor, Vladan Čokić & Juan F. Santibanez. (2021) Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?. Oxidative Medicine and Cellular Longevity 2021, pages 1-16.
Crossref
Crossref
Filomena Longo, Andrea Piolatto, Giovanni Battista Ferrero & Antonio Piga. (2021) Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs. International Journal of Molecular Sciences 22:13, pages 7229.
Crossref
Crossref
Flávia Anchielle Carvalho Silva, Ana Laura Carneiro Gomes Ferreira, Luisa Martins Pimentel, Carlos Henrique Monteiro Maciel Lyra, Manuela Freire Hazin-Costa, Glaucia Lins Guerra, Aderson Silva Araújo & Ariani Impieri Souza. (2021) The Use of Hydroxyurea During Pregnancy in Sickle Cell Anemia Women: A Case Series and Literature Review. Journal of Hematology Research 8, pages 6-10.
Crossref
Crossref
James B. Papizan, Shaina N. Porter, Akshay Sharma & Shondra M. Pruett-Miller. (2021) Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies. The Journal of Biomedical Research 35:2, pages 115.
Crossref
Crossref
Kongtana Trakarnsanga, Chartsiam Tipgomut, Chanatip Metheetrairut, Methichit Wattanapanitch, Archrob Khuhapinant, Saiphon Poldee, Ryo Kurita, Yukio Nakamura, Chatchawan Srisawat & Jan Frayne. (2020) Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient. Scientific Reports 10:1.
Crossref
Crossref
Steven Holshouser, Rebecca Cafiero, Mayra Robinson, Joy Kirkpatrick, Robert A. CaseroJr.Jr., Hyacinth I. Hyacinth & Patrick M. Woster. (2020) Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease. ACS Omega 5:24, pages 14750-14758.
Crossref
Crossref
Lei Yu, Greggory Myers & James D. Engel. (2020) Small molecule therapeutics to treat the β-globinopathies. Current Opinion in Hematology 27:3, pages 129-140.
Crossref
Crossref
Lise J Estcourt, Catherine Kimber, Sally Hopewell, Marialena Trivella, Carolyn Doree & Miguel R Abboud. (2020) Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database of Systematic Reviews 2020:4.
Crossref
Crossref
Rebekah Shaw, Sarah Kappa & Robert S. Nickel. (2020) Inpatient Ordering of Home Hydroxyurea by Residents for Hospitalized Patients With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 42:1, pages e38-e41.
Crossref
Crossref
Mohamed-Rachid Boulassel, Abeer Al-Zubaidi, Shoaib Al-Zadjali, Zahra Al-Qarni, Nidaa Al-Naamany, Ahmed Al-Yarabi, Mohamed Elshinawy & Yasser Wali. (2020) Elevated levels of circulating invariant natural killer cell subsets are skewed toward Th2-like phenotype in children with sickle cell disease. Clinical Immunology 210, pages 108308.
Crossref
Crossref
Coralea Stephanou, Stella Tamana, Anna Minaidou, Panayiota Papasavva, Marina Kleanthous & Petros Kountouris. (2019) Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies. Journal of Clinical Medicine 8:11, pages 1927.
Crossref
Crossref
Li Liu, Xingguo Zhu, Alexander Yu, Christina M Ward & Betty S Pace. (2019) δ-Aminolevulinate induces fetal hemoglobin expression by enhancing cellular heme biosynthesis. Experimental Biology and Medicine 244:14, pages 1220-1232.
Crossref
Crossref
Carmen Cantisani, Norbert Kiss, Ahmad Faiq Naqeshbandi, Giulio Tosti, Sonia Tofani, Claudio Cartoni, Ida Carmosino & Franca Cantoresi. (2019) Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience. Dermatologic Therapy 32:5.
Crossref
Crossref
M.E. Houwing, P.J. de Pagter, E.J. van Beers, B.J. Biemond, E. Rettenbacher, A.W. Rijneveld, E.M. Schols, J.N.J. Philipsen, R.Y.J. Tamminga, K. Fijn van Draat, E. Nur & M.H. Cnossen. (2019) Sickle cell disease: Clinical presentation and management of a global health challenge. Blood Reviews 37, pages 100580.
Crossref
Crossref
Gabriela Queila de Carvalho-Siqueira, Galina Ananina, Bruno Batista de Souza, Murilo Guimarães Borges, Mirta Tomie Ito, Sueli Matilde da Silva-Costa, Igor de Farias Domingos, Diego Arruda Falcão, Iscia Lopes-Cendes, Marcos André Cavalcanti Bezerra, Aderson da Silva Araújo, Antônio Roberto Lucena-Araújo, Marilda de Souza Gonçalves, Sara Teresinha Olalla Saad, Fernando Ferreira Costa & Mônica Barbosa de Melo. (2019)
Whole-exome sequencing indicates
FLG
2 variant associated with leg ulcers in Brazilian sickle cell anemia patients
. Experimental Biology and Medicine 244:11, pages 932-939.
Crossref
Crossref
Aliyu Muhammad, Aliyu Dahiru Waziri, Gilead Ebiegberi Forcados, Babangida Sanusi, Hadiza Sani, Ibrahim Malami, Ibrahim Babangida Abubakar, Habeebah Yahya Oluwatoyin, Otaru Abdulrasheed Adinoyi & Hafsat Abdullahi Mohammed. (2019) Sickling-preventive effects of rutin is associated with modulation of deoxygenated haemoglobin, 2,3-bisphosphoglycerate mutase, redox status and alteration of functional chemistry in sickle erythrocytes. Heliyon 5:6, pages e01905.
Crossref
Crossref
Khuthala Mnika, Gaston K. Mazandu, Mario Jonas, Gift D. Pule, Emile R. Chimusa, Neil A. Hanchard & Ambroise Wonkam. (2019) Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa. Frontiers in Genetics 10.
Crossref
Crossref
Andrea Piccin, Ciaran Murphy, Elva Eakins, Maria Beatrice Rondinelli, Massimo Daves, Cinzia Vecchiato, Dominik Wolf, Corrina Mc Mahon & Owen P. Smith. (2019) Insight into the complex pathophysiology of sickle cell anaemia and possible treatment. European Journal of Haematology 102:4, pages 319-330.
Crossref
Crossref
Sujana Biswas, Arijit Nag, Kanjaksha Ghosh, Rudra Ray, Kaushik Roy, Anish Bandyopadhyay & Maitreyee Bhattacharyya. (2018) Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia. Annals of Hematology 98:2, pages 289-299.
Crossref
Crossref
Sujana Biswas, Rudra Ray, Kaushik Roy, Anish Bandyopadhyay, Kanjaksha Ghosh & Maitreyee Bhattacharyya. (2019) Alpha Globin Gene Mutation: A Major Determinant of Hydroxyurea Response in Transfusion-Dependent HbE-β-Thalassaemia. Acta Haematologica 142:3, pages 132-141.
Crossref
Crossref
Gabriel Ghiaur & Richard J. Jones. 2019. Concise Guide to Hematology. Concise Guide to Hematology
5
13
.
Muhammad Zohaib, Saqib H. Ansari, Tahir S. Shamsi, Roman A. Zubarev & Shamshad Zarina. (2018) Pharmacoproteomics Profiling of Plasma From β‐Thalassemia Patients in Response to Hydroxyurea Treatment. The Journal of Clinical Pharmacology 59:1, pages 98-106.
Crossref
Crossref
Sètondji Cocou Modeste Alexandre Yahouédéhou, Elisângela Vitória Adorno, Caroline Conceição da Guarda, Uche Samuel Ndidi, Suellen Pinheiro Carvalho, Rayra Pereira Santiago, Milena Magalhães Aleluia, Rodrigo Mota de Oliveira & Marilda de Souza Gonçalves. (2018) Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism. The Pharmacogenomics Journal 18:6, pages 730-739.
Crossref
Crossref
Supaporn Khamchun & Visith Thongboonkerd. (2018) Cell cycle shift from G0/G1 to S and G2/M phases is responsible for increased adhesion of calcium oxalate crystals on repairing renal tubular cells at injured site. Cell Death Discovery 4:1.
Crossref
Crossref
Md Fahim Ahmad, Mohd Owais Ansari, Sana Jameel, Ab Latif Wani, Nuzhat Parveen, Hifzur R. Siddique & G.G.H.A. Shadab. (2018) Protective role of nimbolide against chemotherapeutic drug hydroxyurea induced genetic and oxidative damage in an animal model. Environmental Toxicology and Pharmacology 60, pages 91-99.
Crossref
Crossref
Miriam Pons, Claudia M. Reichardt, Dorle Hennig, Abinaya Nathan, Nicole Kiweler, Carol Stocking, Christian Wichmann, Markus Christmann, Falk Butter, Sigrid Reichardt, Günter Schneider, Thorsten Heinzel, Christoph Englert, Jörg Hartkamp, Oliver H. Krämer & Nisintha Mahendrarajah. (2018) Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells. Archives of Toxicology 92:6, pages 2119-2135.
Crossref
Crossref
Sam Behjati, Susan Lindsay, Sarah A. Teichmann & Muzlifah Haniffa. (2018) Mapping human development at single-cell resolution. Development 145:3.
Crossref
Crossref
Silvia R. Brandalise, Rosemary Assis, Angelo B. A. Laranjeira, José Andrés Yunes & Pedro O. de Campos-Lima. (2017) Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis. Experimental Hematology & Oncology 6:1.
Crossref
Crossref
Gift Dineo Pule, Valentina Josiane Ngo Bitoungui, Bernard Chetcha Chemegni, Andre Pascal Kengne & Ambroise Wonkam. (2017) SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon. BMC Research Notes 10:1.
Crossref
Crossref
Odailson Santos Paz, Milena de Jesus Pinheiro, Renan Fernandes do Espirito Santo, Cristiane Flora Villarreal & Marcelo Santos Castilho. (2017) Nanomolar anti-sickling compounds identified by ligand-based pharmacophore approach. European Journal of Medicinal Chemistry 136, pages 487-496.
Crossref
Crossref
Noemi BA Roy, Patricia M Fortin, Katherine R Bull, Carolyn Doree, Marialena Trivella, Sally Hopewell & Lise J Estcourt. (2017) Interventions for chronic kidney disease in people with sickle cell disease. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Crossref
Lise J Estcourt, Patricia M Fortin, Sally Hopewell, Marialena Trivella, Carolyn Doree & Miguel R Abboud. (2017) Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ambroise Wonkam. (2017) Is there a role for pharmacogenetics in the treatment of sickle cell disease?. Pharmacogenomics 18:4, pages 321-325.
Crossref
Crossref
Michael Tarasev, Marina Muchnik, Lucia Light, Kenneth Alfano & Sumita Chakraborty. (2017) Individual variability in response to a single sickling event for normal, sickle cell, and sickle trait erythrocytes. Translational Research 181, pages 96-107.
Crossref
Crossref
Gift Dineo Pule, Shaheen Mowla, Nicolas Novitzky & Ambroise Wonkam. (2016)
Hydroxyurea down‐regulates
BCL11A, KLF
‐
1
and
MYB
through miRNA‐mediated actions to induce γ‐globin expression: implications for new therapeutic approaches of sickle cell disease
. Clinical and Translational Medicine 5:1.
Crossref
Crossref
Noemi BA Roy, Patricia M Fortin, Katherine R Bull, Carolyn Doree, Marialena Trivella, Sally Hopewell & Lise J Estcourt. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Khuthala MnikaGift D. PuleCollet DandaraAmbroise Wonkam. (2016) An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine. OMICS: A Journal of Integrative Biology 20:10, pages 565-574.
Crossref
Crossref
Lise J Estcourt, Patricia M Fortin, Marialena Trivella & Sally Hopewell. (2016) Preoperative blood transfusions for sickle cell disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref